Spinal Muscular Atrophy Mortality Despite Novel Medications: Case Reports.

Am J Phys Med Rehabil

From the Department of Physical Medicine and Rehabilitation, Rutgers University New Jersey Medical School, Newark, New Jersey (JRB); UnIC/RISE Cardiovascular R&D Unit, Faculty of Medicine, University of Porto, Porto, Portugal (NC, MRG); and Noninvasive Ventilatory Support Unit, Pulmonology Department, CAI_Vent: Home Mechanical Ventilation Program, São João University Hospital, Porto, Portugal (MRG).

Published: August 2024

Despite new effective medications, patients with spinal muscular atrophy types 1-3 can continue to have inadequate cough flows to prevent episodes of acute respiratory failure. Ventilator unweanable intubated patients are thought to require tracheostomy tubes. As a result, potentially beneficial medications may be discontinued and patients die despite receiving these medications. Three cases are presented of medically treated, physically strengthening children, with spinal muscular atrophy type 1. All three subsequently died or underwent tracheotomy. However, there is no evidence of extubation attempts to noninvasive ventilatory support settings or optimal mechanical insufflation-exsufflation despite this option being described to be over 98% successful for extubating unweanable medically untreated children with spinal muscular atrophy 1.

Download full-text PDF

Source
http://dx.doi.org/10.1097/PHM.0000000000002467DOI Listing

Publication Analysis

Top Keywords

spinal muscular
16
muscular atrophy
16
children spinal
8
spinal
4
atrophy
4
atrophy mortality
4
despite
4
mortality despite
4
despite novel
4
medications
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!